Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) (NATHAN1)

This study has been completed.
Sponsor:
Collaborators:
Clinquest, Inc.
Ergomed
Quintiles
Information provided by:
MEDA Pharma GmbH & Co. KG
ClinicalTrials.gov Identifier:
NCT00977483
First received: September 14, 2009
Last updated: NA
Last verified: September 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2005
  Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)
No publications provided by MEDA Pharma GmbH & Co. KG

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):